GSK Investigational Site

Vicenza 36100

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2

Studies at this site

• Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed